Nausea - the most common side effect, reported more frequently at higher doses Diarrhoea Vomiting Constipation Abdominal pain or discomfort These side effects were generally mild to moderate in severity and were most common during the dose escalation period (the first 1216 weeks of treatment, when the dose is gradually increased)
Slow-digesting foods include protein, fat, and fiber
Result: the person eats less, more slowly, and feels full for longer, leading to a natural reduction in calorie intake
These include cysteine, glycine, and glutamic acid
Lilly's head of diabetes and obesity Patrik Jonsson recently told Business Insider that orforglipron will likely unlock a much wider market, bringing the benefits of groundbreaking weight-loss drugs to people who can't, or don't want to, use injections